These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34379960)

  • 1. Family vitiligo impact scale: A scale to measure the quality-of-life of family members of patients with vitiligo.
    Agrawal S; Satapathy S; Gupta V; Sreenivas V; Khaitan BK; Ramam M
    Indian J Dermatol Venereol Leprol; 2021; 88(1):32-39. PubMed ID: 34379960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo.
    Krishna GS; Ramam M; Mehta M; Sreenivas V; Sharma VK; Khandpur S
    Indian J Dermatol Venereol Leprol; 2013; 79(2):205-10. PubMed ID: 23442459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach.
    Gupta V; Sreenivas V; Mehta M; Ramam M
    Br J Dermatol; 2019 Mar; 180(3):580-585. PubMed ID: 30085349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument.
    Gupta V; Sreenivas V; Mehta M; Khaitan BK; Ramam M
    Br J Dermatol; 2014 Nov; 171(5):1084-90. PubMed ID: 24805089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
    Salzes C; Abadie S; Seneschal J; Whitton M; Meurant JM; Jouary T; Ballanger F; Boralevi F; Taieb A; Taieb C; Ezzedine K
    J Invest Dermatol; 2016 Jan; 136(1):52-8. PubMed ID: 26763423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL).
    Lilly E; Lu PD; Borovicka JH; Victorson D; Kwasny MJ; West DP; Kundu RV
    J Am Acad Dermatol; 2013 Jul; 69(1):e11-8. PubMed ID: 22365883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a quality of life scale for vitiligo.
    Şenol A; Yücelten AD; Ay P
    Dermatology; 2013; 226(2):185-90. PubMed ID: 23735515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLQI scores in vitiligo: reliability and validity of the Persian version.
    Aghaei S; Sodaifi M; Jafari P; Mazharinia N; Finlay AY
    BMC Dermatol; 2004 Aug; 4():8. PubMed ID: 15294022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia.
    Bin Saif GA; Al-Balbeesi AO; Binshabaib R; Alsaad D; Kwatra SG; Alzolibani AA; Yosipovitch G
    Am J Clin Dermatol; 2013 Dec; 14(6):489-95. PubMed ID: 23839260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Psychometric Testing of the Stigma Assessment Tool for Family Caregivers of People with Mental Illness.
    Shamsaei F; Holtforth MG
    East Asian Arch Psychiatry; 2020 Sep; 30(3):73-78. PubMed ID: 32994374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Vitiligo on Quality of Life and Psychosocial Well-Being in a Nepalese Population.
    Pun J; Randhawa A; Kumar A; Williams V
    Dermatol Clin; 2021 Jan; 39(1):117-127. PubMed ID: 33228855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and psychometric properties of the bipolar disorders knowledge scale.
    Stump TA; Eng ML
    J Affect Disord; 2018 Oct; 238():645-650. PubMed ID: 29957482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ostomy-Q: Development and Psychometric Validation of an Instrument to Evaluate Outcomes Associated with Ostomy Appliances.
    Nafees B; Rasmussen M; LLoyd A
    Ostomy Wound Manage; 2017 Jan; 63(1):12-22. PubMed ID: 28112646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of the family management scale for children with asthma (FMSCA).
    Xing Y; Gu X; Wei Z; Zhang W; Crowder SJ; Duan H
    J Asthma; 2020 Apr; 57(4):441-451. PubMed ID: 30714838
    [No Abstract]   [Full Text] [Related]  

  • 16. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
    Basra MK; Sue-Ho R; Finlay AY
    Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member.
    Elsner SA; Salek SS; Finlay AY; Hagemeier A; Bottomley CJ; Katalinic A; Waldmann A
    Health Qual Life Outcomes; 2021 Mar; 19(1):106. PubMed ID: 33761949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of a Nigerian-Yoruba version of the stroke-specific quality of life scale 2.0.
    Odetunde MO; Akinpelu AO; Odole AC
    Health Qual Life Outcomes; 2017 Oct; 15(1):205. PubMed ID: 29052510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of a quality of life measurement scale in English and Chinese for family caregivers of patients with advanced cancers.
    Cheung YB; Neo SHS; Teo I; Yang GM; Lee GL; Thumboo J; Chia JWK; Koh ARX; Qu DLM; Che WWL; Lau A; Wee HL
    Health Qual Life Outcomes; 2019 Feb; 17(1):35. PubMed ID: 30764839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and validation of the Family Reported Outcome Measure (FROM-16)© to assess the impact of disease on the partner or family member.
    Golics CJ; Basra MK; Finlay AY; Salek S
    Qual Life Res; 2014 Feb; 23(1):317-26. PubMed ID: 23797564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.